ATE435646T1 - Perfluorkohlenstoffe als entzündungshemmendes mittel - Google Patents

Perfluorkohlenstoffe als entzündungshemmendes mittel

Info

Publication number
ATE435646T1
ATE435646T1 AT94929390T AT94929390T ATE435646T1 AT E435646 T1 ATE435646 T1 AT E435646T1 AT 94929390 T AT94929390 T AT 94929390T AT 94929390 T AT94929390 T AT 94929390T AT E435646 T1 ATE435646 T1 AT E435646T1
Authority
AT
Austria
Prior art keywords
perfluorocarbons
inflammatory agent
tissue
reducing
inflammation
Prior art date
Application number
AT94929390T
Other languages
English (en)
Inventor
Bradley Fuhrman
Stephen Flaim
Lynn Hernan
Frances Nesti
Michele Cecile Papo
David Steinhorn
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE435646T1 publication Critical patent/ATE435646T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94929390T 1993-09-29 1994-09-29 Perfluorkohlenstoffe als entzündungshemmendes mittel ATE435646T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/128,811 US5470885A (en) 1993-09-29 1993-09-29 Fluorocarbons as anti-inflammatory agents
PCT/US1994/011092 WO1995008985A1 (en) 1993-09-29 1994-09-29 Perfluorocarbons as anti-inflammatory agents

Publications (1)

Publication Number Publication Date
ATE435646T1 true ATE435646T1 (de) 2009-07-15

Family

ID=22437089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94929390T ATE435646T1 (de) 1993-09-29 1994-09-29 Perfluorkohlenstoffe als entzündungshemmendes mittel

Country Status (8)

Country Link
US (2) US5470885A (de)
EP (1) EP0738142B1 (de)
JP (1) JPH09503211A (de)
AT (1) ATE435646T1 (de)
AU (1) AU691837B2 (de)
CA (1) CA2172601A1 (de)
DE (1) DE69435215D1 (de)
WO (1) WO1995008985A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents
US5861175A (en) * 1996-03-15 1999-01-19 Alliance Pharmaceutical Corp. Use of fluorocarbons for diagnosis and treatment of articular disorders
WO1998016210A1 (en) * 1996-10-15 1998-04-23 Sonus Pharmaceuticals, Inc. Fluorocarbon-containing agents for pulmonary lavage and drug delivery
SE507617C2 (sv) * 1996-12-20 1998-06-29 Siemens Elema Ab Anordning avsedd att användas vid ett behandlingssystem för respiratorvård med vätska
US6255281B1 (en) * 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US20060025348A1 (en) * 1997-05-28 2006-02-02 Pilon Aprile L Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production
US20060281681A1 (en) * 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
DE19823606C2 (de) * 1998-05-27 2002-02-28 Draeger Medical Ag Verwendung von Perfluorcarbone in einem Atemgasgemisch sowie die Vorrichtung
US6894079B1 (en) 1998-12-01 2005-05-17 Alexandre T. Rotta Method for reducing free-radical induced injury
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US6235796B1 (en) 2000-06-26 2001-05-22 Sarfaraz K. Niazi Use of fluorocarbons for the prevention of surgical adhesions
EP1554572B1 (de) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
PT1458360E (pt) 2001-12-19 2011-07-13 Novartis Ag Derivados de indole como agonistas do recetor s1p1
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
JP4079257B2 (ja) * 2002-10-01 2008-04-23 株式会社リコー 静電荷像現像用トナー
US20050118108A1 (en) * 2003-11-28 2005-06-02 Cowan Ada S. Pulmonary delivery of a liquid medicament aerosol
EP3827747A1 (de) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharmainformatiksystem
US7566743B2 (en) * 2005-11-18 2009-07-28 Mark Glazman System and method for medical treatment
WO2007071052A1 (en) * 2005-12-21 2007-06-28 Uti Limited Partnership Treatment of respiratory diseases
EP2063905B1 (de) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Behandlungen von lebererkrankungen durch verabreichung von konjugaten aus rezeptor-assoziierten proteinen
NZ588895A (en) 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
NZ616673A (en) 2009-02-20 2014-08-29 To Bbb Holding B V Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CA2813740C (en) 2009-10-15 2016-08-02 Clarassance, Inc. Recombinant human cc10 protein for treatment of influenza
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
JP2011246396A (ja) * 2010-05-27 2011-12-08 Shiseido Co Ltd 血流促進剤および外用剤
EP2587917A4 (de) * 2010-07-01 2015-05-06 Mtm Res Llc Fluorchemische antifibroblasten-emulsionstherapien
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2023039605A1 (en) * 2021-09-13 2023-03-16 The Board Of Regents Of The University Of Texas System Systemic injection of superheated perfluorocarbon emulsion to improve ventilation and reduce ventilator-induced lung injury

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044121A (en) * 1976-03-11 1977-08-23 Minnesota Mining And Manufacturing Company Hair spray containing fluorocarbon compounds as additives
US4680173A (en) * 1977-04-28 1987-07-14 Norman D. Burger Aerosol dispensing system
US4490351A (en) * 1982-03-15 1984-12-25 Children's Hospital Medical Center Methods of treating disorders of an eye with liquid perfluorocarbons
US4543202A (en) * 1984-03-23 1985-09-24 E. I. Du Pont De Nemours And Company Aerosol propellant compositions
US5192528A (en) * 1985-05-22 1993-03-09 Liposome Technology, Inc. Corticosteroid inhalation treatment method
US4865836A (en) * 1986-01-14 1989-09-12 Fluoromed Pharmaceutical, Inc. Brominated perfluorocarbon emulsions for internal animal use for contrast enhancement and oxygen transport
US4987154A (en) * 1986-01-14 1991-01-22 Alliance Pharmaceutical Corp. Biocompatible, stable and concentrated fluorocarbon emulsions for contrast enhancement and oxygen transport in internal animal use
US5284645A (en) * 1987-08-05 1994-02-08 Alliance Pharmaceutical Corp. Fluorocarbon emulsions containing amino acid based anti-inflamatory agents and buffer systems
US4927623A (en) * 1986-01-14 1990-05-22 Alliance Pharmaceutical Corp. Dissolution of gas in a fluorocarbon liquid
AU2807689A (en) * 1986-09-19 1989-03-01 Chemex Pharmaceuticals Inc. Method for the treatment of body tissues and the administration of drugs thereto
US4897262A (en) * 1988-03-22 1990-01-30 Playtex Jhirmack, Inc. Non-aerosol hair spray composition
US5028428A (en) * 1988-08-09 1991-07-02 Estee Lauder Inc. Anti-irritant and desensitizing compositions and methods of their use
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5213570A (en) * 1990-12-14 1993-05-25 Mallinckrodt Medical, Inc. System and method for oxygenation of the pericardium
JPH06507404A (ja) * 1991-05-01 1994-08-25 ヘンリー　エム．ジャクソン　ファウンデイション　フォー　ザ　アドバンスメント　オブ　ミリタリー　メディスン 感染性の呼吸性疾患の治療方法
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
ES2124260T3 (es) * 1991-05-03 1999-02-01 Alliance Pharma Respiracion liquida parcial de fluorocarbonos.
US5470885A (en) * 1993-09-29 1995-11-28 The Research Foundation Of The State University Of New York Fluorocarbons as anti-inflammatory agents

Also Published As

Publication number Publication date
EP0738142A4 (de) 1997-07-16
US5733939A (en) 1998-03-31
EP0738142B1 (de) 2009-07-08
JPH09503211A (ja) 1997-03-31
CA2172601A1 (en) 1995-04-06
AU691837B2 (en) 1998-05-28
DE69435215D1 (de) 2009-08-20
WO1995008985A1 (en) 1995-04-06
AU7846994A (en) 1995-04-18
US5470885A (en) 1995-11-28
EP0738142A1 (de) 1996-10-23

Similar Documents

Publication Publication Date Title
DE69435215D1 (de) Perfluorkohlenstoffe als entzündungshemmendes Mittel
YU47204B (sh) Derivati didehidro-vitamina d3
EA199800667A1 (ru) Новые фенантридины
DK0782855T3 (da) Nimesulid til ekstern anvendelse
NO954441L (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
DE69523951T2 (de) Stabilisierung der prostaglandinzusammensetzungen
DK1640009T3 (da) Östrogenforbindelser som antimitotiske midler
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
DK0558529T3 (da) Farmaceutisk præparat til behandling af forlænget koagulationstid
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
DE69531356D1 (de) Kristallisierung von levobupivacaine und deren analogen
SE9303788D0 (sv) Biomedicinsk elektrod
DK0449099T3 (da) Hidtil ukendt retinoid heraf og anvendelser heraf til lægemidler
ATE300300T1 (de) Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel
ES2051461T3 (es) Medios de contraste.
DE69414194T2 (de) Aminosäurederivate und ihre Verwendung als Enkephalinase-Inhibitoren
FR2713444B1 (fr) Composition liquide désinfectante et ses utilisations.
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
AR245433A1 (es) Purificacion de 2,2-dicloro-1,1,1-trifluoretano.
DK0453603T3 (da) Piroxicamholdige farmaceutiske præparater til topisk anvendelse
ES2128030T3 (es) Procedimiento para la obtencion de gamma butirolactona.
FR2569569B1 (fr) Exerciseur destine notamment au travail du grand ecart.
ATE187430T1 (de) In position 10 substituierte 1,8-dihydroxy-9(10h)-anthracenon pharmazeutika
ES2152315T3 (es) Xamoneline tartrato.
ES2121204T3 (es) Preparacion de fluoro-nucleosidos e intermedios para su uso en ella.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties